Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shruti Mathur

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
The Biochemical Journal|June 3, 2020
Novel pyrano 1,3 oxazine based ligand inhibits the epigenetic reader hBRD2 in glioblastomaPrashant Deshmukh, Shruti Mathur, Gejo Gangadharan, et al.
Acta Crystallographica. Section D, Structural Biology|July 11, 2023
Structural and biochemical insights into purine-based drug molecules in hBRD2 delineate a unique binding mode opening new vistas in the design of inhibitors of the BET familyAishwarya H Arole, Prashant Deshmukh, Ashok Sridhar, et al.
Infection and Immunity|June 17, 2009
Impact of preexisting vector-specific immunity on vaccine potency: characterization of listeria monocytogenes-specific humoral and cellular immunity in humans and modeling studies using recombinant vaccines in miceMeredith L Leong, Johannes Hampl, Weiqun Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2011
A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune inductionDung T Le, Dirk G Brockstedt, Ran Nir-Paz, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
The Biochemical Journal|June 3, 2020
Novel pyrano 1,3 oxazine based ligand inhibits the epigenetic reader hBRD2 in glioblastomaPrashant Deshmukh, Shruti Mathur, Gejo Gangadharan, et al.
Acta Crystallographica. Section D, Structural Biology|July 11, 2023
Structural and biochemical insights into purine-based drug molecules in hBRD2 delineate a unique binding mode opening new vistas in the design of inhibitors of the BET familyAishwarya H Arole, Prashant Deshmukh, Ashok Sridhar, et al.
Infection and Immunity|June 17, 2009
Impact of preexisting vector-specific immunity on vaccine potency: characterization of listeria monocytogenes-specific humoral and cellular immunity in humans and modeling studies using recombinant vaccines in miceMeredith L Leong, Johannes Hampl, Weiqun Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2011
A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune inductionDung T Le, Dirk G Brockstedt, Ran Nir-Paz, et al.
Pageof 2